Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis
Frontiers in Oncology · 23.07.2026 · 16
DOI: 10.3389/fonc.2026.1802360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 23.07.2026. Verfasst von Hui Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Affiliated Jinyang Hospital of Guizhou Medical University (The Second People's Hospital of Guiyang), Guiyang, China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The Kaiser score and apparent diffusion coefficient (ADC) have been proposed as diagnostic adjuncts to reduce unnecessary biopsies in Breast Imaging Reporting and Data System (BI-RADS) 4 breast lesions. However, which specific histopathologic entities are prone to misclassification by each diagnostic model remains poorly characterized, limiting clinical guidance for borderline cases.
Objective
To compare the diagnostic performance of the Kaiser score, ADC, and their combination (Kaiser+) stratified by lesion morphology, and to identify histopathologic subtypes most susceptible to misclassification.
Methods
This retrospective study included 222 patients with BI-RADS 4 breast lesions confirmed by histopathology. Two radiologists independently evaluated lesions using the Kaiser score and ADC values (threshold: 1.4 × 10 -3 mm²/s). Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis, and misclassification patterns were analyzed by pathologic subtype using McNemar’s test with Bonferroni correction.
Results
The Kaiser score achieved the highest area under the curve (AUC) of 0.901 (95% CI: 0.856–0.941), followed by Kaiser+ (AUC 0.890; 95% CI: 0.845–0.930) and ADC alone (AUC 0.733; 95% CI: 0.666–0.800; p < 0.001 vs. Kaiser). Kaiser demonstrated superior performance in mass lesions (AUC 0.926; 95% CI: 0.878–0.965) compared with non-mass enhancement (NME) (AUC 0.801; 95% CI: 0.681–0.905). Pathology-stratified analysis revealed distinct misclassification patterns: fibroadenoma, breast hyperplasia, and intraductal papilloma accounted for most FP cases, with ADC showing significantly higher FP rates (66.1%; 95% CI: 57.3%–73.9%) than Kaiser (19.8%; 95% CI: 13.7%–27.8%) or Kaiser+ (17.4%; 95% CI: 11.6%–25.1%; p <0.001). Among malignant lesions, ductal carcinoma in situ (DCIS) and mucinous carcinoma were the majority of frequently misclassified as FN across all models.
Conclusion
The Kaiser score outperformed ADC alone in BI-RADS 4 lesions. Pathology-stratified analysis identified subtype-specific diagnostic pitfalls: benign cellular and proliferative lesions drive FP cases (especially with ADC), while low-conspicuity malignancies (DCIS, mucinous carcinoma) drive FN cases. Awareness of these patterns may guide individualized biopsy decisions in clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Affiliated Jinyang Hospital of Guizhou Medical University (The Second People's Hospital of Guiyang), Guiyang, China.
- The First People's Hospital of Zunyi, Zunyi, China.
- Department of Medical Imaging, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Breast and Thyroid Surgery Center, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Department of Nuclear Medicine, Guizhou Provincial People's Hospital, Guiyang, China.
Zitieren
APA
Zhou, H., Wei, L., Zhou, Z., Jiang, G., Li, S., & Zeng, X. (2026). Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1802360
Vancouver
Zhou H, Wei L, Zhou Z, Jiang G, Li S, Zeng X. Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1802360
BibTeX
@article{Zhou2026,
author = {Zhou, Hui and Wei, Ling and Zhou, Zhiqin and Jiang, Guoyuan and Li, Shiguang and Zeng, Xianchun},
title = {Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1802360}
}
EUVIMED